Sapir Venture Partners

Lidwave is a developer of advanced 3D sensing solutions aimed at transforming industries reliant on LiDAR technology. By introducing a novel three-dimensional sensing architecture, the company addresses significant limitations in traditional LiDAR and radar systems, particularly concerning bandwidth constraints. Its innovative Finite Coherence Ranging (FCR) technology delivers enhanced four-dimensional sensing capabilities, enabling precise Doppler and depth information. This breakthrough allows businesses to enhance automation across various sectors, including autonomous vehicles, industrial robotics, and smart cities, ultimately facilitating smarter and safer decision-making. Lidwave's approach not only resolves the challenges associated with existing sensing methods but also positions it as a leader in disruptive sensing technology.

Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.

Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.

DeepCure Inc. is a biotechnology company based in Boston, Massachusetts, specializing in artificial intelligence-driven drug discovery. Founded in 2018, DeepCure develops innovative solutions for small-molecule drug development, utilizing advanced deep learning algorithms and a proprietary database of chemical compounds. The company offers services such as De-novo Lead Discovery, which employs AI algorithms to assess potential drug candidates from a virtual library, and Artificial Intelligence-driven Lead Optimization, aimed at enhancing drug development processes. Additionally, DeepCure's platform includes a molecular database designed to maximize the diversity and synthesizability of chemical compounds. By integrating AI predictive modeling and a feedback loop, DeepCure focuses on creating effective therapeutics for unmet medical needs, ultimately aiming to expedite the development of novel precision medicines.

Genetika+ is a medical platform focused on personalizing treatment for depression by utilizing advanced biological, medical, and genetic data. The company has developed an innovative testing tool that predicts the most effective drug therapy for individual patients, thus enabling faster treatment solutions with reduced side effects and lower dosing requirements. By employing a combination of stem-cell technology, genomics, and artificial intelligence, Genetika+ aims to optimize treatment while also aiding pharmaceutical companies in enhancing their product offerings and streamlining clinical trials. This approach not only tailors treatments to specific patient needs but also seeks to advance care for psychiatric and neurological conditions.

Miter is set out to fix bad meetings. The company provides its users with a specific, outcome-oriented, shared goal and a simple list of topics for meetings. Milter aims to help motivated people improve their meetings and make better use of their teams' time and energy.

OUR MISSION Fabric is on a mission to create a world where everyone belongs, one in-person interaction at a time. We do this by augmenting shared experiences, starting with the number one industry that brings people together: Sports. OUR TEAM Fabric’s team is a diverse group of technologists, entrepreneurs, humanists, executives, mathematicians, and designers who are devoted to creating a world where everyone belongs through the creation of the world’s most accessible and innovative technology platform. OUR PLATFORM Fabric is a venture-backed geospatial web3 platform for sports teams and leagues. Our platform transforms the fan experience by delivering immersive real-time AR, blockchain, social, and gaming experiences, powered by no-code tools and an AI engine that understands the team’s needs. Fabric Spaces transform smartphones into an interactive and social 3D jumbotron in every fan's pocket, unlocking a new layer of the in-stadium experience. Fabric transports fans to the unlimited possibilities that come from the blending of physical and digital worlds all under the official banner of their favorite team. We call this the Reality-First Metaverse™, where fans join the team.

Diptera.ai is a Jerusalem-based company specializing in innovative mosquito control solutions. The firm has developed a technology that employs the sterile insect technique, utilizing advanced optics, computer vision, and artificial intelligence. Its ready-to-use module is designed to release sterile male mosquitoes over several weeks, allowing municipal corporations to implement large-scale mosquito control initiatives effectively. This approach eliminates the need for traditional mosquito rearing and sorting facilities, making the technology more affordable and accessible for municipalities. By focusing on biological solutions, Diptera.ai aims to address the challenges posed by mosquito-borne diseases and improve public health outcomes.

Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.

Gabriel is focused on enhancing safety and security through the development of an advanced network of devices designed to respond to threats such as active shooter situations. In light of increasing safety concerns globally, the company has engineered an innovative alert and crisis management system that is both user-friendly and cost-effective. Targeting schools and public buildings, Gabriel's system integrates smart sensors and software to deliver instant alerts and essential communication tools, aimed at improving preparedness and response during emergencies. This approach offers a more affordable solution compared to traditional safety measures, making it accessible to a wider range of institutions.

Strattic Ltd. is a technology company based in Jerusalem, Israel, founded in 2016. It specializes in providing a hosted website security and optimization platform that focuses on converting CMS-based websites, particularly those built on WordPress, into static versions. This transformation enhances website performance by making them faster, more scalable, and significantly more secure, effectively reducing vulnerabilities associated with dynamic sites. Strattic's platform operates on a serverless architecture, allowing site owners to manage their WordPress content seamlessly while the dynamic aspects are isolated behind authentication measures. With a simple one-click deployment, site owners can publish their websites as static sites, which consist of HTML, CSS, and JavaScript, ensuring a secure online presence without compromising functionality or ease of use.

Genetika+ is a medical platform focused on personalizing treatment for depression by utilizing advanced biological, medical, and genetic data. The company has developed an innovative testing tool that predicts the most effective drug therapy for individual patients, thus enabling faster treatment solutions with reduced side effects and lower dosing requirements. By employing a combination of stem-cell technology, genomics, and artificial intelligence, Genetika+ aims to optimize treatment while also aiding pharmaceutical companies in enhancing their product offerings and streamlining clinical trials. This approach not only tailors treatments to specific patient needs but also seeks to advance care for psychiatric and neurological conditions.

CaliberMind provides a B2B customer data platform for revenue marketers that integrates data, enables marketing attribution, engagement scoring, funnel insights, and churn analysis to optimize sales and marketing outcomes. Positioned as a buyer intelligence solution, the platform helps organizations leverage their sales, marketing, and customer data to improve productivity, engagement, and revenue through features such as account engagement, chain-based attribution, and marketing workflow automation, and by linking data across touchpoints to inform pipeline decisions and identify churn risk.

Lance, established in 2017 and based in New York, specializes in providing expense management and tax prediction software tailored to freelancers. Its platform offers integrated services including financing, legal, and taxation assistance, enabling freelancers to consolidate and monitor invoices, payments, and accounts. Lance's software also streamlines expense organization and maximizes deductions, while facilitating business registration for freelancers.

Goodlight is a risk analytics platform that focuses on identifying potential issues within an organization's workforce. The company employs digital technology and machine learning to analyze and assess employee risk profiles after hiring. By monitoring various data sources for abnormalities, Goodlight's platform alerts clients to early signs of employee risk, allowing organizations to proactively address these issues. This capability enables clients to mitigate workforce risks effectively and reduce the costs associated with incidents within their organizations.

DeepCure Inc. is a biotechnology company based in Boston, Massachusetts, specializing in artificial intelligence-driven drug discovery. Founded in 2018, DeepCure develops innovative solutions for small-molecule drug development, utilizing advanced deep learning algorithms and a proprietary database of chemical compounds. The company offers services such as De-novo Lead Discovery, which employs AI algorithms to assess potential drug candidates from a virtual library, and Artificial Intelligence-driven Lead Optimization, aimed at enhancing drug development processes. Additionally, DeepCure's platform includes a molecular database designed to maximize the diversity and synthesizability of chemical compounds. By integrating AI predictive modeling and a feedback loop, DeepCure focuses on creating effective therapeutics for unmet medical needs, ultimately aiming to expedite the development of novel precision medicines.

SynVaccine Ltd. is a biotechnology company based in Tel Aviv, Israel, that focuses on the development of preventive viral vaccines targeting major human pathogens. Founded in 2013 by Tuval Ben Yehezkel, the company possesses licenses for innovative technologies that facilitate the computational rational design of viral genomes, as well as the physical DNA editing of viral vaccine genome libraries. This expertise positions SynVaccine at the forefront of vaccine development, aiming to enhance the effectiveness and efficiency of vaccine production against various viral threats.

Genetika+ is a medical platform focused on personalizing treatment for depression by utilizing advanced biological, medical, and genetic data. The company has developed an innovative testing tool that predicts the most effective drug therapy for individual patients, thus enabling faster treatment solutions with reduced side effects and lower dosing requirements. By employing a combination of stem-cell technology, genomics, and artificial intelligence, Genetika+ aims to optimize treatment while also aiding pharmaceutical companies in enhancing their product offerings and streamlining clinical trials. This approach not only tailors treatments to specific patient needs but also seeks to advance care for psychiatric and neurological conditions.

ConsortiaTX, Inc. is a seed stage, pre-clinical bio-therapeutics company that emerged from research laboratories at Brigham & Women’s Hospital and Children’s Hospital in Boston. The company’s intellectual property around food allergies and the human gut microbiome is based on the work of Lynn Bry, M.D., Ph.D., Georg Gerber, M.D., Ph.D. (both at BWH), and Talal Chatilla, Ph.D. (at CHB) and others.

PlanetWatchers, Inc. is a technology company based in San Francisco, California, founded in 2016. It specializes in geospatial analytics and offers a software-as-a-service (SaaS) platform that enables enterprises, governments, and non-governmental organizations to monitor their natural assets across various sectors, including forestry and oil and gas. Utilizing advanced machine learning algorithms and synthetic aperture radar (SAR) technology, the company transforms extensive manual data collection into rapid automated analysis. This capability allows for efficient monitoring and alerting systems that provide critical insights for managing large-scale assets, supporting industries such as crop insurance by ensuring accurate analysis and validation of claims on a global scale.